MVP Holdings Inc. MVPT
Set alert
0.00 USD 0.00 0.00%
At close · Oct 29
0.0001 Day range 0.0001
0.0001 52-week range 0.0001
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.0001
- Prev close
- 0.0001
- Mkt cap
- 100
- Vol
- 7
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.0001
- High
- 0.0001
News
- New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths
- Napco Security: How The MVP Platform Secures Napco's Future
- BioVaxys Presents Further Validation of the Robust Immune Response from a Combination of MVP-S with Checkpoint Inhibitors and Low-Dose Cyclophosphamide in Ovarian Cancer
- First Horizon Recognized with a 2026 Training MVP Award by Training Magazine
- BioVaxys Reports Positive Phase 2 Data for Maveropepimut (MVP-S) + Pembrolizumab and Low-Dose Cyclophosphamide in Metastatic Bladder Cancer
- BioVaxys Reports Positive Clinical Study Results from Phase 1B/2 PESCO Trial of MVP-S with Pembrolizumab (Keytruda (TM)) and Low-Dose Cyclophosphamide for Patients with Recurrent Epithelial Ovarian Cancer (EOC)
- Digitalage Announces MVP Launch for Live, Creator-First Media Platform
- BioVaxys Announces Positive Phase 1 Clinical Study Results with Maveropepimut-S (MVP-S) in Women with Hormone Receptor Positive/HER2 Negative (HR+/HER2-) Stage II-III Breast Cancer
- Firestone Partners, Matterhorn Venture Partners, and Fox Capital Partners Form Joint Venture for Atlanta Industrial Acquisition
- Mountain Valley Pipeline, LLC Files Formal Application Requesting FERC Authorization to Construct MVP Boost
Your note
Sign in to keep a note on MVPT — it syncs with the Stock Master app.